These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 9811455
1. Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin. Rodriguez-Puebla ML, LaCava M, Gimenez-Conti IB, Johnson DG, Conti CJ. Oncogene; 1998 Oct 29; 17(17):2251-8. PubMed ID: 9811455 [Abstract] [Full Text] [Related]
2. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells. Gill RM, Slack R, Kiess M, Hamel PA. Exp Cell Res; 1998 Oct 10; 244(1):157-70. PubMed ID: 9770359 [Abstract] [Full Text] [Related]
3. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases. Alexandrow MG, Moses HL. J Cell Biochem; 1998 Sep 15; 70(4):528-42. PubMed ID: 9712150 [Abstract] [Full Text] [Related]
4. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion. Gray-Bablin J, Rao S, Keyomarsi K. Cancer Res; 1997 Feb 15; 57(4):604-9. PubMed ID: 9044834 [Abstract] [Full Text] [Related]
5. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes. Flink IL, Oana S, Maitra N, Bahl JJ, Morkin E. J Mol Cell Cardiol; 1998 Mar 15; 30(3):563-78. PubMed ID: 9515032 [Abstract] [Full Text] [Related]
6. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells. Zhu WY, Jones CS, Kiss A, Matsukuma K, Amin S, De Luca LM. Exp Cell Res; 1997 Aug 01; 234(2):293-9. PubMed ID: 9260897 [Abstract] [Full Text] [Related]
7. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F. Hiyama H, Iavarone A, Reeves SA. Oncogene; 1998 Mar 26; 16(12):1513-23. PubMed ID: 9569018 [Abstract] [Full Text] [Related]
8. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma. Flørenes VA, Lu C, Bhattacharya N, Rak J, Sheehan C, Slingerland JM, Kerbel RS. Oncogene; 1999 Jan 28; 18(4):1023-32. PubMed ID: 10023678 [Abstract] [Full Text] [Related]
9. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes. Haddad MM, Xu W, Schwahn DJ, Liao F, Medrano EE. Exp Cell Res; 1999 Dec 15; 253(2):561-72. PubMed ID: 10585280 [Abstract] [Full Text] [Related]
10. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1. Korkolopoulou P, Christodoulou P, Konstantinidou AE, Thomas-Tsagli E, Kapralos P, Davaris P. Hum Pathol; 2000 Jun 15; 31(6):751-60. PubMed ID: 10872671 [Abstract] [Full Text] [Related]
11. Activation of c-Myc uncouples DNA replication from activation of G1-cyclin-dependent kinases. Pusch O, Bernaschek G, Eilers M, Hengstschläger M. Oncogene; 1997 Aug 07; 15(6):649-56. PubMed ID: 9264405 [Abstract] [Full Text] [Related]
12. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression. Hiyama H, Iavarone A, LaBaer J, Reeves SA. Oncogene; 1997 May 29; 14(21):2533-42. PubMed ID: 9191053 [Abstract] [Full Text] [Related]
13. Control of E2F activity by p21Waf1/Cip1. Delavaine L, La Thangue NB. Oncogene; 1999 Sep 23; 18(39):5381-92. PubMed ID: 10498892 [Abstract] [Full Text] [Related]
14. Conserved region 2 of adenovirus E1A has a function distinct from pRb binding required to prevent cell cycle arrest by p16INK4a or p27Kip1. Alevizopoulos K, Sanchez B, Amati B. Oncogene; 2000 Apr 13; 19(16):2067-74. PubMed ID: 10803468 [Abstract] [Full Text] [Related]
15. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor. Khwaja F, Djakiew D. Mol Carcinog; 2003 Mar 13; 36(3):153-60. PubMed ID: 12619038 [Abstract] [Full Text] [Related]
16. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells. Cartee L, Wang Z, Decker RH, Chellappan SP, Fusaro G, Hirsch KG, Sankala HM, Dent P, Grant S. Cancer Res; 2001 Mar 15; 61(6):2583-91. PubMed ID: 11289135 [Abstract] [Full Text] [Related]
17. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells. Ehmann GL, McLean TI, Bachenheimer SL. Virology; 2000 Feb 15; 267(2):335-49. PubMed ID: 10662629 [Abstract] [Full Text] [Related]
18. K-ras modulates the cell cycle via both positive and negative regulatory pathways. Fan J, Bertino JR. Oncogene; 1997 May 29; 14(21):2595-607. PubMed ID: 9191059 [Abstract] [Full Text] [Related]
19. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1. Halaban R, Cheng E, Zhang Y, Mandigo CE, Miglarese MR. Oncogene; 1998 May 14; 16(19):2489-501. PubMed ID: 9627115 [Abstract] [Full Text] [Related]
20. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol. Gewirtz DA, Di YM, Randolph JK, Jain PT, Valerie K, Bullock S, Nath N, Chellappan SP. Arch Biochem Biophys; 2001 Apr 15; 388(2):243-52. PubMed ID: 11368161 [Abstract] [Full Text] [Related] Page: [Next] [New Search]